Report post

What is the market cap of BeiGene?

BeiGene market cap history and chart from 2014 to 2022. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. BeiGene market cap as of February 17, 2023 is $24.17B.

How much is BeiGene stock worth?

Biotechnology company Amgen announced Thursday it is investing $2.7 billion in BeiGene, taking a 20.5% stake in the Chinese biotech firm. The all-cash deal values BeiGene at $174.85 per American depository share, a 25% premium to BeiGene’s closing price on the Nasdaq on Wednesday. BeiGene’s stock jumped 7% in after-hours trading Thursday.

What is BeiGene's market capitalization?

BeiGene's current market capitalization is $18.8 b. - Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor SHANGHAI and HONG KONG, June 26, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company...

The World's Leading Crypto Trading Platform

Get my welcome gifts